Business Description
Salus
ISIN : SI0031110453
Total Employee Number:
723Compare
Compare
Traded in other countries / regions
SALR.SloveniaE3U.Germany IPO Date
1999-08-12Description
Salus is a Slovenia-based company engaged in the wholesale and distribution of medical products. It offers medicines, medical devices, medical supplies, dietary supplements, cosmetics to hospitals, pharmacies, and other customers.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.33 | |||||
Equity-to-Asset | 0.32 | |||||
Debt-to-Equity | 0.33 | |||||
Debt-to-EBITDA | 0.93 | |||||
Interest Coverage | 19.77 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 5.18 | |||||
Beneish M-Score | -2.54 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.6 | |||||
3-Year EBITDA Growth Rate | 12.5 | |||||
3-Year EPS without NRI Growth Rate | 7.1 | |||||
3-Year FCF Growth Rate | 11.1 | |||||
3-Year Book Growth Rate | 6.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 46.45 | |||||
9-Day RSI | 49.64 | |||||
14-Day RSI | 51.73 | |||||
3-1 Month Momentum % | 6.45 | |||||
6-1 Month Momentum % | -0.75 | |||||
12-1 Month Momentum % | 53.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.28 | |||||
Quick Ratio | 0.77 | |||||
Cash Ratio | 0.06 | |||||
Days Inventory | 43.26 | |||||
Days Sales Outstanding | 45.24 | |||||
Days Payable | 65.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.79 | |||||
Dividend Payout Ratio | 0.51 | |||||
3-Year Dividend Growth Rate | 7.2 | |||||
Forward Dividend Yield % | 1.79 | |||||
5-Year Yield-on-Cost % | 2.98 | |||||
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | 0.7 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 11.99 | |||||
Operating Margin % | 2.9 | |||||
Net Margin % | 2.49 | |||||
EBITDA Margin % | 4.48 | |||||
FCF Margin % | 2.47 | |||||
OCF Margin % | 3.39 | |||||
ROE % | 20.89 | |||||
ROA % | 7.18 | |||||
ROIC % | 13.21 | |||||
3-Year ROIIC % | 5.91 | |||||
ROC (Joel Greenblatt) % | 30.45 | |||||
ROCE % | 22.78 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 30.45 | |||||
PE Ratio without NRI | 30.45 | |||||
Shiller PE Ratio | 48.51 | |||||
Price-to-Owner-Earnings | 20.9 | |||||
PEG Ratio | 2.96 | |||||
PS Ratio | 0.76 | |||||
PB Ratio | 6.02 | |||||
Price-to-Tangible-Book | 7.33 | |||||
Price-to-Free-Cash-Flow | 30.47 | |||||
Price-to-Operating-Cash-Flow | 22.26 | |||||
EV-to-EBIT | 23.57 | |||||
EV-to-EBITDA | 17.57 | |||||
EV-to-Revenue | 0.79 | |||||
EV-to-FCF | 31.79 | |||||
Price-to-GF-Value | 2.05 | |||||
Price-to-Projected-FCF | 2.62 | |||||
Price-to-DCF (Earnings Based) | 0.98 | |||||
Price-to-DCF (FCF Based) | 1.7 | |||||
Price-to-Median-PS-Value | 2.77 | |||||
Price-to-Peter-Lynch-Fair-Value | 3.52 | |||||
Price-to-Graham-Number | 3.15 | |||||
| Price-to-Net-Current-Asset-Value | 23.51 | |||||
Earnings Yield (Greenblatt) % | 4.24 | |||||
FCF Yield % | 3.27 | |||||
Forward Rate of Return (Yacktman) % | 10.75 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Salus Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 727.648 | ||
| EPS (TTM) (€) | 2.2 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 1.54 | ||
| 3-Year Sortino Ratio | 5.87 | ||
| Volatility % | 30.09 | ||
| 14-Day RSI | 51.73 | ||
| 14-Day ATR (€) | 1.286437 | ||
| 20-Day SMA (€) | 67.125 | ||
| 12-1 Month Momentum % | 53.49 | ||
| 52-Week Range (€) | 43 - 72.5 | ||
| Shares Outstanding (Mil) | 8.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Salus Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Salus Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| EUR 0.600000 Cash Dividend | 2026-04-28 | 63.00 (-0.79%) | ||
| EUR 0.600000 Cash Dividend | 2026-01-15 | 50.00 (+0.00%) | ||
| 78:1 Stock Split | 2025-05-28 | 30.77 (+0.00%) | ||
| EUR 0.512821 Cash Dividend | 2025-04-25 | 29.74 (+0.00%) | ||
| EUR 0.512821 Cash Dividend | 2025-01-09 | 27.18 (+0.00%) |
Show
Entries
Salus Frequently Asked Questions
What is Salus(XLJU:SALR)'s stock price today?
The current price of XLJU:SALR is €67.00. The 52 week high of XLJU:SALR is €72.50 and 52 week low is €43.00.
When is next earnings date of Salus(XLJU:SALR)?
The next earnings date of Salus(XLJU:SALR) is .
Does Salus(XLJU:SALR) pay dividends? If so, how much?
The Dividend Yield %  of Salus(XLJU:SALR) is 1.79% (As of Today), Highest Dividend Payout Ratio of Salus(XLJU:SALR) was 1.2. The lowest was 0.44. And the median was 0.6. The  Forward Dividend Yield % of Salus(XLJU:SALR) is 1.79%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Salus
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers